Keyword: ophthalmic drugs

News

Recipharm in Ophthalmic Collaboration with Alcon

29.12.2015 - Swedish drug developer and toll manufacturer Recipharm has signed a long-term agreement with Swiss eye-care treatment company Alcon, part of Novartis, to manufacture a range of...

News

Valeant, Ackman Make $47 billion offer for Allergan

24.04.2014 - Canada's Valeant Pharmaceuticals International and activist investor Bill Ackman have made an unsolicited $47 billion bid to buy Botox maker Allergan in a move to create one of the...